Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of Experimental Systemic Inflammation (Septic Inflammation) and Chronic Bronchitis by New Phytoformula BL Containing Broussonetia papyrifera and Lonicera japonica

  • Ko, Hyun Jeong (College of Pharmacy, Kangwon National University) ;
  • Kwon, Oh Song (College of Pharmacy, Kangwon National University) ;
  • Jin, Jeong Ho (College of Pharmacy, Kangwon National University) ;
  • Son, Kun Ho (Department Food and Nutr., Andong National University) ;
  • Kim, Hyun Pyo (College of Pharmacy, Kangwon National University)
  • Received : 2012.10.19
  • Accepted : 2012.12.18
  • Published : 2013.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Broussonetia papyrifera and Lonicera japonica have long been used in the treatment of inflammatory disorders in Chinese medicine, especially respiratory inflammation. Previously, a new phytoformula (BL) containing B. papyrifera and L. japonica was found to exert strong anti-inflammatory activity against several animal models of inflammation, especially against an animal model of acute bronchitis. In the present investigation, the effects of BL on animal models of septic inflammation and chronic bronchitis are examined. Against lipopolysaccharide (LPS)-induced septic inflammation in mice, BL (200-400 mg/kg) reduced the induction of some important proinflammatory cytokines. At 1 h after LPS treatment, BL was found to considerably inhibit TNF-${\alpha}$ production when measured by cytokine array. At 3 h after LPS treatment, BL inhibited the induction of several proinflammatory cytokines, including IFN-${\gamma}$ and IL-$1{\beta}$, although dexamethasone, which was used as a reference, showed a higher inhibitory action on these biomarkers. Against chronic bronchitis induced by LPS/elastase instillation in rats for 4 weeks, BL (200-400 mg/kg/day) significantly inhibited cell recruitment in bronchoalveolar lavage fluid. Furthermore, BL considerably reduced lung injury, as revealed by histological observation. Taken together, these results indicate that BL may have a potential to treat systemic septic inflammation as well as chronic bronchitis.

Keywords

References

  1. Barnes, P. J. (1999) Novel approaches and targets for treatment of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, S72-S79. https://doi.org/10.1164/ajrccm.160.supplement_1.17
  2. Batt, D. G. (1992) 5-Lipoxygenase inhibitors and their anti-inflammatory activities. Prog. Med. Chem. 29, 1-63. https://doi.org/10.1016/S0079-6468(08)70004-3
  3. Cheng, Z. J., Lin, C. N., Hwang, T. L. and Teng, C. M. (2001) Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 61, 939-946. https://doi.org/10.1016/S0006-2952(01)00543-3
  4. Chi, Y. S., Jong, H. G., Son, K. H., Chang, H. W., Kang, S. S. and Kim, H. P. (2001) Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases. Biochem. Pharmacol. 62, 1185-1191. https://doi.org/10.1016/S0006-2952(01)00773-0
  5. Ganesan, S., Faris, A. N., Comstock, A. T., Chattoraj, S. S., Chattoraj, A., Burgess, J. R., Curtis, J. L., Martinez, F. J., Zick, S., Hershenson, M. B. and Sajjan, U. S. (2010) Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir. Res. 11, 113. https://doi.org/10.1186/1465-9921-11-113
  6. Jeffery, P. K. (2001) Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164, S28-S38. https://doi.org/10.1164/ajrccm.164.supplement_2.2106061
  7. Jin, J. H., Lim, H., Kwon, S. Y., Son, K. H. and Kim, H. P. (2010) Anti-inflammatory activity of the total flavonoid fraction from Broussonetia papyrifera in combination with Lonicera japonica. Biomol. Ther. 18, 197-204. https://doi.org/10.4062/biomolther.2010.18.2.197
  8. Ko, H. J., Jin, J. H., Kwon, O. S., Kim, J. T., Son, K. H. and Kim, H. P. (2011) Inhibition of experimental lung inflammation and bronchitis by phytoformula containing Broussonetia papyrifera and Lonicera japonica. Biomol. Ther. 19, 324-330. https://doi.org/10.4062/biomolther.2011.19.3.324
  9. Kwak, W. J., Moon, T. C., Lin, C. X., Rhyn, H. G., Jung, H., Lee, E., Kwon, D. Y., Son, K. H., Kim, H. P., Kang, S. S., Murakami, M., Kudo, I. and Chang, H. W. (2003) Papyriflavonol A from Broussonetia papyrifera inhibits the passive cutaneous anaphylaxic reaction and has a secretory phospholipase $A_{2}$ inhibitory activity. Biol. Pharm. Bull. 26, 299-302. https://doi.org/10.1248/bpb.26.299
  10. Lee, S. J., Shin, E. J., Son, K. H., Chang, H. W., Kang, S. S. and Kim, H. P. (1995) Anti-inflammatory activity of the major constituents of Lonicera japonica. Arch. Pharm. Res. 18, 133-135. https://doi.org/10.1007/BF02979147
  11. Lee, S. J., Son, K. H., Chang, H. W., Kang, S. S. and Kim, H. P. (1998) Anti-inflammatory activity of Lonicera japonica. Phytother. Res. 12, 445-447. https://doi.org/10.1002/(SICI)1099-1573(199809)12:6<445::AID-PTR317>3.0.CO;2-5
  12. Lin, L. W., Chen, H. Y., Wu, C. R., Liao, P. M., Lin, Y. T., Hsieh, M. T. and Ching, H. (2008) Comparison with various parts of Broussonetia papyrifera as to the antinociceptive and anti-inflammatory activities in rodents. Biosci. Biotechnol. Biochem. 72, 2377-2384. https://doi.org/10.1271/bbb.80276
  13. Reid, D. J. and Pham, N. T. (2012) Roflumilast: a novel treatment for chronic obstructive pulmonary disease. Ann. Pharmacother. 46, 521-529. https://doi.org/10.1345/aph.1Q646
  14. Son, K. H., Kwon, S. J., Chang, H. W., Kim, H. P. and Kang, S. S. (2001) Papyriflavonol A, a new prenylated flavonoid from Broussonetia papyrifera. Fitoterapia 72, 456-458. https://doi.org/10.1016/S0367-326X(00)00329-4
  15. Starcher, B. and Williams, I. (1989) A method for intratracheal instillation of endotoxin into the lungs of mice. Lab. Anim. 23, 234-240. https://doi.org/10.1258/002367789780810536
  16. Wu, W. T. (2012) Evaluation of anti-inflammatory effects of Broussonetia papyrifera stem bark. Indian J. Pharmacol. 44, 26-30. https://doi.org/10.4103/0253-7613.91862

Cited by

  1. Transcriptional regulation of the paper mulberry under cold stress as revealed by a comprehensive analysis of transcription factors vol.15, pp.1, 2015, https://doi.org/10.1186/s12870-015-0489-2
  2. Protective Effect of Yinhua Miyanling Tablet on Lipopolysaccharide-Induced Inflammation through Suppression of NLRP3/Caspase-1 Inflammasome in Human Peripheral Blood Mononuclear Cells vol.2016, 2016, https://doi.org/10.1155/2016/2758140
  3. De Novo Assembly of Expressed Transcripts and Global Transcriptomic Analysis from Seedlings of the Paper Mulberry (Broussonetia kazinoki x Broussonetia papyifera) vol.9, pp.5, 2014, https://doi.org/10.1371/journal.pone.0097487
  4. Study on anti-inflammatory efficacy and correlative ingredients with pharmacodynamics detected in acute inflammation rat model serum from Caulis Lonicerae japonicae vol.23, pp.6, 2016, https://doi.org/10.1016/j.phymed.2016.01.016
  5. AP-1-Targeted Anti-Inflammatory Activities of the Nanostructured, Self-Assembling S5 Peptide vol.2015, 2015, https://doi.org/10.1155/2015/451957
  6. Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KK Ay mice vol.7, pp.4, 2017, https://doi.org/10.1016/j.apsb.2017.04.010
  7. Thymoquinone Prevents Myocardial and Perivascular Fibrosis Induced by Chronic Lipopolysaccharide Exposure in Male Rats - Thymoquinone and Cardiac Fibrosis - vol.21, pp.4, 2013, https://doi.org/10.3831/kpi.2018.21.032
  8. The effect of environment on the microbiome associated with the roots of a native woody plant under different climate types in China vol.103, pp.9, 2019, https://doi.org/10.1007/s00253-019-09747-6
  9. Plant Products as Inhibitors of Coronavirus 3CL Protease vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.583387
  10. Skin Moisturizing Effects of a Microneedle Patch Containing Hyaluronic Acid and Lonicerae flos vol.9, pp.2, 2013, https://doi.org/10.3390/pr9020321